文献速递糖尿病

卒中前血糖控制与大血管闭塞性卒中合并糖尿病患者取栓术后的功能结局

Prestroke Glucose Control and Functional Outcome in Patients With Acute Large Vessel Occlusive Stroke and Diabetes After Thrombectomy.
PubMed 文献 · Diabetes Care · 2021-07-02

该研究基于韩国卒中临床研究登记数据库,纳入2009年1月至2020年3月因急性大血管闭塞性卒中合并糖尿病接受动脉内取栓术的患者1351例,评估入院时HbA1c水平与3个月改良Rankin量表功能结局的关联。结果显示入院HbA1c越高,早期神经功能恶化越常见,且HbA1c阈值7.0-7.1%以上与良好功能结局几率降低显著相关,该关联在各亚组中一致。结论提示卒中前血糖控制目标HbA1c≤7.0%可能有利于神经功能恢复。

要点

  • 入院HbA1c较高与取栓后早期神经功能恶化更常见相关。
  • HbA1c阈值7.0-7.1%以上与良好功能结局几率降低显著相关。
  • 卒中前HbA1c目标≤7.0%可能有利于取栓后神经功能恢复。

核心结论

  • 卒中前血糖控制目标HbA1c≤7.0%可能有利于大血管闭塞性卒中合并糖尿病接受动脉内取栓术患者的神经功能恢复。

研究设计与样本

  • 基于韩国卒中临床研究登记数据库的回顾性队列研究,纳入2009年1月至2020年3月接受动脉内取栓术的急性大血管闭塞性卒中合并糖尿病患者1351例。

主要发现

  • 入院HbA1c较高者早期神经功能恶化更常见(按HbA1c五分位P=0.02,按HbA1c cutoff 7.0% P=0.003)。
  • 入院HbA1c较高与良好功能结局几率降低显著相关,阈值在7.0-7.1%。
  • 该关联在年龄、性别、卒中亚型、闭塞部位、再通程度、溶栓方式、症状至穿刺时间及治疗时期等亚组中一致。

关键数值与推荐

  • HbA1c阈值7.0-7.1%以上与良好功能结局几率降低显著相关。
  • 按HbA1c五分位分析早期神经功能恶化P=0.02,按HbA1c cutoff 7.0%分析P=0.003。

临床怎么用

  • 对合并糖尿病的大血管闭塞性卒中患者,取栓术前评估HbA1c有助于识别功能结局风险较高者。
  • 卒中前将HbA1c控制至≤7.0%可能作为改善取栓后神经功能恢复的血糖管理目标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate whether prestroke glucose control is associated with functional outcomes in patients with acute large vessel occlusive stroke and diabetes who underwent intra-arterial thrombectomy (IAT). RESEARCH DESIGN AND METHODS: From the Clinical Research Center for Stroke-Korea registry, we included patients with emergent large vessel occlusive stroke with diabetes who underwent IAT between January 2009 and March 2020. The association between the HbA1c level at admission and functional outcomes (modified Rankin Scale at 3 months after the index stroke) was assessed. RESULTS: A total of 1,351 patients were analyzed. Early neurological deterioration was more common in patients with higher levels of HbA1c at admission (P = 0.02 according to HbA1c quintiles, P = 0.003 according to an HbA1c cutoff value of 7.0%) than in those with lower HbA1c levels. Higher HbA1c levels at admission were significantly associated with decreased odds of favorable functional outcomes at a threshold of 7.0-7.1%. The association was consistently observed in subgroups divided according to age, sex, stroke subtype, occlusion site, degree of recanalization, thrombolysis modalities, time from symptom onset to groin puncture, and treatment period. CONCLUSIONS: Prestroke glucose control with a target HbA1c of ≤7.0% may be beneficial for neurological recovery in patients with diabetes undergoing IAT for large vessel occlusive stroke, regardless of stroke subtype, bridging intravenous thrombolysis, occlusion site, degree of recanalization, and treatment period.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Chang JY, Kim WJ, Kwon JH, et al. Prestroke Glucose Control and Functional Outcome in Patients With Acute Large Vessel Occlusive Stroke and Diabetes After Thrombectomy. Diabetes Care. 2021. PMID: 34215632. doi:10.2337/dc21-0271

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。